ESO/LinkedIn
Jul 21, 2026, 03:19
Where Does Stroke Treatment Go Next on The Latest ESOC 2026 TV Studio Session – ESO
European Stroke Organisation shared on LinkedIn:
”In this ESOC 2026 TV Studio session, anchors Manon Kappelhof and Gerrit M. Große are joined by Urs Fischer and Johanna Ospel to reflect on the latest evidence surrounding medium and distal vessel occlusions and their implications for the future of stroke treatment.
Key themes include:
- Why improved reperfusion rates have not consistently translated into better clinical outcomes
- Whether specific patient subgroups, particularly those with more severe neurological deficits, may still benefit from endovascular treatment
- How future studies can optimise patient selection, outcome measures and trial design to better evaluate treatment effects”
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 17:08Khusi Dhara: Why Women Need to Pay Attention to Iron
-
Sep 3, 2026, 16:54Ralf Ludwig։ Testing Human-Targeted Therapies in a Human Immune System
-
Sep 3, 2026, 16:35Mohsen Salimi: Non-Contrast Chest CT as a Biomarker for Mild-to-Moderate Anemia
-
Sep 3, 2026, 16:10Tanzeel Alamin Almahdi Gorashi: NLR as an Accessible Biomarker for Monitoring Pediatric Sickle Cell Anemia
-
Sep 3, 2026, 15:42Manuel De Jesus: Innovating Anemia Monitoring Through Biomedical Engineering and Digital Technology
-
Sep 3, 2026, 15:37Hadis Nabipoor: QICL2026 Highlights the Critical Importance of Transfusion Safety
-
Sep 3, 2026, 15:32Gopal Patidar: The ISBT Haemovigilance Working Party Sharing Knowledge and Promoting Best Practices
-
Sep 3, 2026, 15:24Bhalchandra Kawdikar: FDA Approves Rusfertide for Polycythemia Vera
-
Sep 3, 2026, 15:18Massimo Martino: Redefining Allogeneic Transplantation in Myelofibrosis